Shawn M. Carter

Key takeaways: Mean albumin loss was significantly higher for patients undergoing expanded hemodialysis without affecting pre-dialysis serum albumin.

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients with kidney disease and type 2 diabetes, according to researchers.In January, the first GLP-1 receptor agonist, semaglutide (Ozempic, Novo Nordisk), was approved by the FDA for use by adults with type 2 diabetes and chronic kidney disease to reduce the risk for worsening CKD

Worldwide prevalence of kidney failure requiring dialysis nearly tripled since 1990 to reach 4.6 million cases in 2023, according to results of the Global Burden of Disease study 2023.Researchers reported differences in the number of diagnoses across regions, as well as between men and women. The analysis also found that type 2 diabetes and hypertension were the leading drivers of kidney failure

Prophylactic antibiotic use before tunneled cuffed catheter insertion was not linked to a lower rate of early hemodialysis catheter-related bloodstream infections, a study found.

Once you've opened an IRA, you should invest your IRA contributions. Make sure you understand the fees for and investments in your account.